MDM2 and cancer: Although MDM2 is mainly known as an E3-ubiquitin ligase for p53 degradation [12], we observed in the G/G SNP309 cancer cell lines that the excess MDM2 did not lead to decreased p53 protein levels by degradation (Figure 2 and [14]).